Last update 01 Nov 2024

STEAP2 x TGFBR2

Basic Info

Related Targets
STEAP2TGFBR2

Related

1
Drugs associated with STEAP2 x TGFBR2
AZD0754
Target
STEAP2 x TGFBR2
Mechanism
STEAP2 inhibitors [+1]
Active Org.
AstraZeneca PLCAstraZeneca PLC
Originator Org.
AstraZeneca PLCAstraZeneca PLC
Active Indication
Metastatic Prostate Carcinoma [+1]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
2
Clinical Trials associated with STEAP2 x TGFBR2
NCT06194461 / Not yet recruitingNot Applicable
A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)
NCT06267729 / Active, not recruitingPhase 1/2
A Phase I/II Open Label Study to Evaluate the Safety, Cellular Kinetics, and Efficacy of AZD0754, a Chimeric Antigen Receptor (CAR) T-cell Therapy Directed Against STEAP2, in Adult Participants With Metastatic Prostate Cancer: APOLLO
100 Clinical Results associated with STEAP2 x TGFBR2
Login to view more data
100 Translational Medicine associated with STEAP2 x TGFBR2
Login to view more data
0 Patents (Medical) associated with STEAP2 x TGFBR2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free